Published in BMC Bioinformatics on March 22, 2010
Advances in structure elucidation of small molecules using mass spectrometry. Bioanal Rev (2010) 1.76
Mass spectrometry strategies in metabolomics. J Biol Chem (2011) 1.60
Automated workflows for accurate mass-based putative metabolite identification in LC/MS-derived metabolomic datasets. Bioinformatics (2011) 1.57
Bioinformatics Tools for Mass Spectroscopy-Based Metabolomic Data Processing and Analysis. Curr Bioinform (2012) 1.31
Metabolite identification and quantitation in LC-MS/MS-based metabolomics. Trends Analyt Chem (2012) 1.23
Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol (2016) 1.14
CASMI: And the Winner is . . . Metabolites (2013) 1.12
Searching molecular structure databases with tandem mass spectra using CSI:FingerID. Proc Natl Acad Sci U S A (2015) 1.10
In silico identification software (ISIS): a machine learning approach to tandem mass spectral identification of lipids. Bioinformatics (2012) 1.06
Development of Ecom₅₀ and retention index models for nontargeted metabolomics: identification of 1,3-dicyclohexylurea in human serum by HPLC/mass spectrometry. J Chem Inf Model (2012) 1.06
Computational mass spectrometry for small molecules. J Cheminform (2013) 1.01
Systematic structural characterization of metabolites in Arabidopsis via candidate substrate-product pair networks. Plant Cell (2014) 1.00
CFM-ID: a web server for annotation, spectrum prediction and metabolite identification from tandem mass spectra. Nucleic Acids Res (2014) 1.00
Small Molecule Identification with MOLGEN and Mass Spectrometry. Metabolites (2013) 0.96
Stable isotope-labeling studies in metabolomics: new insights into structure and dynamics of metabolic networks. Bioanalysis (2014) 0.96
MolFind: a software package enabling HPLC/MS-based identification of unknown chemical structures. Anal Chem (2012) 0.93
Using fragmentation trees and mass spectral trees for identifying unknown compounds in metabolomics. Trends Analyt Chem (2015) 0.93
MS2Analyzer: A software for small molecule substructure annotations from accurate tandem mass spectra. Anal Chem (2014) 0.92
The Critical Assessment of Small Molecule Identification (CASMI): Challenges and Solutions. Metabolites (2013) 0.90
Fragmentation trees for the structural characterisation of metabolites. Rapid Commun Mass Spectrom (2012) 0.90
Tackling CASMI 2012: Solutions from MetFrag and MetFusion. Metabolites (2013) 0.89
CASMI-The Small Molecule Identification Process from a Birmingham Perspective. Metabolites (2013) 0.89
Metabolite Identification through Machine Learning- Tackling CASMI Challenge Using FingerID. Metabolites (2013) 0.89
Recent Advance in Liquid Chromatography/Mass Spectrometry Techniques for Environmental Analysis in Japan. Mass Spectrom (Tokyo) (2015) 0.87
Metabolite identification through multiple kernel learning on fragmentation trees. Bioinformatics (2014) 0.87
Open-access metabolomics databases for natural product research: present capabilities and future potential. Front Bioeng Biotechnol (2015) 0.86
After the feature presentation: technologies bridging untargeted metabolomics and biology. Curr Opin Biotechnol (2014) 0.85
BiNChE: a web tool and library for chemical enrichment analysis based on the ChEBI ontology. BMC Bioinformatics (2015) 0.85
MetAssign: probabilistic annotation of metabolites from LC-MS data using a Bayesian clustering approach. Bioinformatics (2014) 0.84
Fragment formula calculator (FFC): determination of chemical formulas for fragment ions in mass spectrometric data. Anal Chem (2014) 0.84
Structural mass spectrometry of tissue extracts to distinguish cancerous and non-cancerous breast diseases. Mol Biosyst (2014) 0.83
MetaDB a Data Processing Workflow in Untargeted MS-Based Metabolomics Experiments. Front Bioeng Biotechnol (2014) 0.82
ECMDB 2.0: A richer resource for understanding the biochemistry of E. coli. Nucleic Acids Res (2015) 0.82
MetFrag relaunched: incorporating strategies beyond in silico fragmentation. J Cheminform (2016) 0.82
LC-MS metabolomics from study design to data-analysis - using a versatile pathogen as a test case. Comput Struct Biotechnol J (2013) 0.81
Computational analyses of spectral trees from electrospray multi-stage mass spectrometry to aid metabolite identification. Metabolites (2013) 0.81
Metabolomics reveals increased isoleukotoxin diol (12,13-DHOME) in human plasma after acute Intralipid infusion. J Lipid Res (2012) 0.81
Discriminating precursors of common fragments for large-scale metabolite profiling by triple quadrupole mass spectrometry. Bioinformatics (2015) 0.81
MINEs: open access databases of computationally predicted enzyme promiscuity products for untargeted metabolomics. J Cheminform (2015) 0.80
Solving CASMI 2013 with MetFrag, MetFusion and MOLGEN-MS/MS. Mass Spectrom (Tokyo) (2014) 0.80
Automatic Compound Annotation from Mass Spectrometry Data Using MAGMa. Mass Spectrom (Tokyo) (2014) 0.79
Evaluating plant immunity using mass spectrometry-based metabolomics workflows. Front Plant Sci (2014) 0.79
Evidence for quorum sensing and differential metabolite production by a marine bacterium in response to DMSP. ISME J (2016) 0.79
Winners of CASMI2013: Automated Tools and Challenge Data. Mass Spectrom (Tokyo) (2014) 0.79
Metabolic modelling in the development of cell factories by synthetic biology. Comput Struct Biotechnol J (2012) 0.79
In-Depth Characterization and Validation of Human Urine Metabolomes Reveal Novel Metabolic Signatures of Lower Urinary Tract Symptoms. Sci Rep (2016) 0.79
HAMMER: automated operation of mass frontier to construct in silico mass spectral fragmentation libraries. Bioinformatics (2013) 0.78
Automated LC-HRMS(/MS) approach for the annotation of fragment ions derived from stable isotope labeling-assisted untargeted metabolomics. Anal Chem (2014) 0.78
Computational Metabolomics: A Framework for the Million Metabolome. Chem Res Toxicol (2016) 0.77
Chemical structure identification in metabolomics: computational modeling of experimental features. Comput Struct Biotechnol J (2013) 0.77
Enhanced acylcarnitine annotation in high-resolution mass spectrometry data: fragmentation analysis for the classification and annotation of acylcarnitines. Front Bioeng Biotechnol (2015) 0.77
Rethinking Mass Spectrometry-Based Small Molecule Identification Strategies in Metabolomics. Mass Spectrom (Tokyo) (2014) 0.77
Two birds with one stone: doing metabolomics with your proteomics kit. Proteomics (2013) 0.76
Untargeted Metabolomics Strategies-Challenges and Emerging Directions. J Am Soc Mass Spectrom (2016) 0.76
Multifaceted investigation of metabolites during nitrogen fixation in Medicago via high resolution MALDI-MS imaging and ESI-MS. J Am Soc Mass Spectrom (2014) 0.76
Identification of Anthropogenic Compounds in Urban Environments and Evaluation of Automated Methods for Reading Fragmentation-A Case of River Water. Mass Spectrom (Tokyo) (2016) 0.75
Trends in the application of high-resolution mass spectrometry for human biomonitoring: An analytical primer to studying the environmental chemical space of the human exposome. Environ Int (2017) 0.75
Technical Challenges in Mass Spectrometry-Based Metabolomics. Mass Spectrom (Tokyo) (2016) 0.75
LipidFrag: Improving reliability of in silico fragmentation of lipids and application to the Caenorhabditis elegans lipidome. PLoS One (2017) 0.75
High-resolution filtering for improved small molecule identification via GC/MS. Anal Chem (2015) 0.75
Analysis of Metabolomics Datasets with High-Performance Computing and Metabolite Atlases. Metabolites (2015) 0.75
Sponge exhalent seawater contains a unique chemical profile of dissolved organic matter. PeerJ (2017) 0.75
Prioritization of putative metabolite identifications in LC-MS/MS experiments using a computational pipeline. Proteomics (2013) 0.75
Development of Database Assisted Structure Identification (DASI) Methods for Nontargeted Metabolomics. Metabolites (2016) 0.75
Checkpoints for Preliminary Identification of Small Molecules found Enriched in Autophagosomes and Activated Mast Cell Secretions Analyzed by Comparative UPLC/MS(e). Anal Methods (2016) 0.75
Reduced levels of dopamine and altered metabolism in brains of HPRT knock-out rats: a new rodent model of Lesch-Nyhan Disease. Sci Rep (2016) 0.75
Method for the Compound Annotation of Conjugates in Nontargeted Metabolomics Using Accurate Mass Spectrometry, Multistage Product Ion Spectra and Compound Database Searching. Mass Spectrom (Tokyo) (2015) 0.75
Metabolic Fingerprinting to Assess the Impact of Salinity on Carotenoid Content in Developing Tomato Fruits. Int J Mol Sci (2016) 0.75
Fragmentation trees reloaded. J Cheminform (2016) 0.75
Fast metabolite identification with Input Output Kernel Regression. Bioinformatics (2016) 0.75
Decoding and Discrimination of Chemical Cues and Signals: Avoidance of Predation and Competition during Parental Care Behavior in Sympatric Poison Frogs. PLoS One (2015) 0.75
The Chemistry Development Kit (CDK): an open-source Java library for Chemo- and Bioinformatics. J Chem Inf Comput Sci (2003) 10.73
GMD@CSB.DB: the Golm Metabolome Database. Bioinformatics (2004) 7.33
Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics (2007) 6.93
Optimization and testing of mass spectral library search algorithms for compound identification. J Am Soc Mass Spectrom (1994) 3.46
Current trends and future requirements for the mass spectrometric investigation of microbial, mammalian and plant metabolomes. Phys Biol (2008) 2.11
Mass spectral metabonomics beyond elemental formula: chemical database querying by matching experimental with computational fragmentation spectra. Anal Chem (2008) 1.83
FiD: a software for ab initio structural identification of product ions from tandem mass spectrometric data. Rapid Commun Mass Spectrom (2008) 1.51
MassBank: a public repository for sharing mass spectral data for life sciences. J Mass Spectrom (2010) 6.16
ISA software suite: supporting standards-compliant experimental annotation and enabling curation at the community level. Bioinformatics (2010) 5.60
mzML--a community standard for mass spectrometry data. Mol Cell Proteomics (2010) 4.81
Toward interoperable bioscience data. Nat Genet (2012) 4.72
A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol (2012) 4.48
Highly sensitive feature detection for high resolution LC/MS. BMC Bioinformatics (2008) 3.70
MetaboLights--an open-access general-purpose repository for metabolomics studies and associated meta-data. Nucleic Acids Res (2012) 3.32
CAMERA: an integrated strategy for compound spectra extraction and annotation of liquid chromatography/mass spectrometry data sets. Anal Chem (2011) 2.76
Are we regionalized enough? Early-neonatal deaths in low-risk births by the size of delivery units in Hesse, Germany 1990-1999. Int J Epidemiol (2002) 1.82
Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci U S A (2004) 1.80
Critical assessment of alignment procedures for LC-MS proteomics and metabolomics measurements. BMC Bioinformatics (2008) 1.80
TraML--a standard format for exchange of selected reaction monitoring transition lists. Mol Cell Proteomics (2011) 1.65
Metabolome analysis of biosynthetic mutants reveals a diversity of metabolic changes and allows identification of a large number of new compounds in Arabidopsis. Plant Physiol (2008) 1.62
Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur Radiol (2010) 1.41
Meeting Report from the Second "Minimum Information for Biological and Biomedical Investigations" (MIBBI) workshop. Stand Genomic Sci (2010) 1.35
MetFusion: integration of compound identification strategies. J Mass Spectrom (2013) 1.30
Impact of the 3D microenvironment on phenotype, gene expression, and EGFR inhibition of colorectal cancer cell lines. PLoS One (2013) 1.27
Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains. Int J Antimicrob Agents (2006) 1.13
Does high field MRI allow an earlier diagnosis of multiple sclerosis? J Neurol (2008) 1.04
Consensus structure elucidation combining GC/EI-MS, structure generation, and calculated properties. Anal Chem (2012) 1.03
Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery. Int J Antimicrob Agents (2009) 1.01
Profiling of secondary metabolites in root exudates of Arabidopsis thaliana. Phytochemistry (2014) 0.99
Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents. Clin Microbiol Rev (2013) 0.99
Clinical pharmacokinetics and pharmacodynamics of tigecycline. Clin Pharmacokinet (2009) 0.96
Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis. J Antimicrob Chemother (2013) 0.96
The Risa R/Bioconductor package: integrative data analysis from experimental metadata and back again. BMC Bioinformatics (2014) 0.93
A pharmacokinetic/pharmacodynamic mathematical model accurately describes the activity of voriconazole against Candida spp. in vitro. Int J Antimicrob Agents (2008) 0.92
Evaluation of quantitative ultrasound tissue characterization of the cervix and cervical length in the prediction of premature delivery for patients with spontaneous preterm labor. Am J Obstet Gynecol (2003) 0.91
Database supported candidate search for metabolite identification. J Integr Bioinform (2011) 0.91
Penetration of ertapenem into skeletal muscle and subcutaneous adipose tissue in healthy volunteers measured by in vivo microdialysis. J Antimicrob Chemother (2006) 0.90
Discriminatory features of acute transverse myelitis: a retrospective analysis of 45 patients. J Neurol Sci (2004) 0.90
Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations. Int J Antimicrob Agents (2009) 0.89
Metabolite profiling and beyond: approaches for the rapid processing and annotation of human blood serum mass spectrometry data. Anal Bioanal Chem (2013) 0.88
Computer-assisted detection of pulmonary embolism: performance evaluation in consensus with experienced and inexperienced chest radiologists. Eur Radiol (2007) 0.88
Carbohydrate-lectin recognition of sequence-defined heteromultivalent glycooligomers. J Am Chem Soc (2014) 0.88
Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neurosci (2002) 0.87
Building blocks for automated elucidation of metabolites: machine learning methods for NMR prediction. BMC Bioinformatics (2008) 0.87
Clinical pharmacokinetics and pharmacodynamics of clopidogrel. Clin Pharmacokinet (2015) 0.86
Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents (2009) 0.85
TACC3-TSC2 maintains nuclear envelope structure and controls cell division. Cell Cycle (2010) 0.85
Comparing bound and unbound protein structures using energy calculation and rotamer statistics. In Silico Biol (2002) 0.85
Soft-tissue penetration of ceftobiprole in healthy volunteers determined by in vivo microdialysis. Antimicrob Agents Chemother (2009) 0.85
Artefacts in statistical analyses of network motifs: general framework and application to metabolic networks. J R Soc Interface (2012) 0.85
Association of the PPARgamma gene polymorphism Pro12Ala with delayed onset of multiple sclerosis. Neurosci Lett (2008) 0.83
Multifocal myelitis in Behçet's disease. Neurology (2003) 0.82
Variability in caesarean section rates for very preterm births at 28-31 weeks of gestation in 10 European regions: results of the MOSAIC project. Eur J Obstet Gynecol Reprod Biol (2010) 0.82
Assessment of fetal lung development by quantitative ultrasonic tissue characterization: a methodical study. Prenat Diagn (2004) 0.81
[Excessive hyperchylomicronemia--a rare cause of acute retrosternal and epigastric pain in pregnancy]. Herz (2003) 0.81
On the early diagnosis of IVIg-responsive chronic multifocal acquired motor axonopathy. J Neurol (2004) 0.81
When is protein binding important? J Pharm Sci (2013) 0.81
Pharmacokinetic-pharmacodynamic relationships of central nervous system effects of scopolamine in healthy subjects. Br J Clin Pharmacol (2011) 0.81
Application of a mechanism-based disease systems model for osteoporosis to clinical data. J Pharmacokinet Pharmacodyn (2013) 0.81
Mechanical carbohydrate sensors based on soft hydrogel particles. Angew Chem Int Ed Engl (2013) 0.81
Late onset Alexander's disease presenting as cerebellar ataxia associated with a novel mutation in the GFAP gene. J Neurol (2010) 0.81
Fetoscopic placement of a transurethral stent for intrauterine obstructive uropathy. J Urol (2004) 0.80
The underestimation of immaturity in late preterm infants. Arch Gynecol Obstet (2012) 0.80
Clinical implementation of genetic testing in medicine: a US regulatory science perspective. Br J Clin Pharmacol (2014) 0.80
The value of quantitative ultrasound tissue characterization of the cervix and rapid fetal fibronectin in predicting preterm delivery. J Perinat Med (2005) 0.80
A novel contact model for AFM indentation experiments on soft spherical cell-like particles. Soft Matter (2014) 0.80
Specific adhesion of carbohydrate hydrogel particles in competition with multivalent inhibitors evaluated by AFM. Langmuir (2014) 0.79
The expression of microfilament-associated cell-cell contacts in brain endothelial cells is modified by IFN-beta1a (Rebif). J Interferon Cytokine Res (2004) 0.79
Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis. Neuroradiology (2007) 0.79
Visual field changes in methotrexate therapy. Case report and review of the literature. J Med Liban (2006) 0.79
Mechanobiology: correlation between mechanical stability of microcapsules studied by AFM and impact of cell-induced stresses. Small (2010) 0.79
Thermoresponsive PEG-based polymer layers: surface characterization with AFM force measurements. Langmuir (2010) 0.78
Use and abuse of cesarean section -- a transatlantic evaluation. J Perinat Med (2009) 0.78
Pharmacokinetic/pharmacodynamic modelling and in vitro simulation of dynamic voriconazole-Candida interactions. Int J Antimicrob Agents (2009) 0.78
Impact of maternal body mass index on the cesarean delivery rate in Germany from 1990 to 2012. J Perinat Med (2015) 0.78
Quantification of protein-materials interaction by soft colloidal probe spectroscopy. Phys Chem Chem Phys (2015) 0.78
Subgraph fluctuations in random graphs. Phys Rev E Stat Nonlin Soft Matter Phys (2012) 0.78
Suppression of IL-2 and IFN-gamma production in women with spontaneous preterm labor. J Perinat Med (2006) 0.78
Condylar motion after open and closed treatment of mandibular condylar fractures. J Oral Maxillofac Surg (2005) 0.78
Identification and quantification of protein adducts formed by metabolites of 1-methoxy-3-indolylmethyl glucosinolate in vitro and in mouse models. Chem Res Toxicol (2014) 0.77
Nanomechanical properties of supramolecular self-assembled whiskers determined by AFM force mapping. Langmuir (2010) 0.77
Fampridine improves severe dysarthria in secondary-progressive multiple sclerosis. Mult Scler (2012) 0.77
Frequencies of the G-protein beta3 subunit C825T polymorphism and the delta 32 mutation of the chemokine receptor-5 in patients with multiple sclerosis. Neurosci Lett (2002) 0.77
Intrapartum management of nonreassuring fetal heart rate patterns: a randomized controlled trial of fetal pulse oximetry. Am J Obstet Gynecol (2004) 0.77
Microfluidics meets soft layer-by-layer films: selective cell growth in 3D polymer architectures. Lab Chip (2012) 0.77
EXIT (Ex utero Intrapartum Treatment) in lymphatic malformations of the head and neck: discussion of three cases and proposal of an EXIT-TTP (Team Time Procedure) list. Int J Pediatr Otorhinolaryngol (2011) 0.76
IFN-beta1a (Rebif) modifies the expression of microfilament-associated cell-cell contacts in C6 glioma cells. J Interferon Cytokine Res (2003) 0.76
Twenty-four-hour CTG monitoring: comparison of normal pregnancies of 25-30 weeks of gestation versus 36-42 weeks of gestation. Arch Gynecol Obstet (2006) 0.76
The cystathionine beta-synthase variant c.844_845ins68 protects against CNS demyelination in X-linked adrenoleukodystrophy. Hum Mutat (2006) 0.76
Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections. Pharmacogenet Genomics (2017) 0.75
Risk of neonatal death on weekends vs weekdays. JAMA (2003) 0.75
Long-term effects of a multimodal approach including immunoadsorption for the treatment of myasthenic crisis. Artif Organs (2006) 0.75
C1-inhibitor activity and plasma concentrations in patients with monoclonal gammopathies: implications for treatment with recombinant interferon-beta 1b. Mult Scler (2004) 0.75
Database driven test case generation for protein-protein docking. Bioinformatics (2004) 0.75
Impact of fetal blood sampling on vaginal delivery and neonatal outcome in deliveries complicated by pathologic fetal heart rate: a population based cohort study. J Perinat Med (2006) 0.75
Assessment of rapid fetal fibronectin in predicting preterm delivery. Obstet Gynecol (2005) 0.75
Decision-to-Delivery Time and Perinatal Complications in Emergency Cesarean Section. Dtsch Arztebl Int (2017) 0.75
Preparation of multivalent glycan micro- and nano-arrays: general discussion. Faraday Discuss (2019) 0.75
Synthesis of porous PEG microgels using CaCO3 microspheres as hard templates. Macromol Rapid Commun (2012) 0.75
nmrML: a community supported open data standard for the description, storage, and exchange of NMR data. Anal Chem (2017) 0.75
Magnetic porous sugar-functionalized PEG microgels for efficient isolation and removal of bacteria from solution. Biomacromolecules (2013) 0.75
Mat-pKa calculation tool development for evaluation of acidity constants from solubility profiles--large study of 41 compounds. Int J Pharm (2012) 0.75
Anti-JC-virus antibody prevalence in a German MS cohort. Mult Scler (2012) 0.75